The rising cases of cancer have been driving the value of the global exosomes drug market. The number of cancer cases was close to 23.39 million in 2023. The prevalence of cancer diseases is likely to grow at the rate of 6.6% during the forecast period of 2024-2032. With this growth rate, the number of cases is likely to reach nearly 41.40 million